Use of nonsteroidal anti-inflammatory drugs and survival following breast cancer diagnosis

Cancer Epidemiology Biomarkers and Prevention

Volumn 21, Issue 1, 2012, Pages 239-242

  Li, Yanli ^a   Brasky, Theodore M ^c   Nie, Jing ^a   Ambrosone, Christine B ^b   McCann, Susan E ^b   Shields, Peter G ^d   Trevisan, Maurizio ^e   Edge, Stephen B ^b   Freudenheim, Jo L ^a  

^a UNIVERSITY AT BUFFALO   (United States)

^b ROSWELL PARK CANCER INSTITUTE   (United States)

^c USA   (United States)

^d OHIO STATE UNIVERSITY   (United States)

^e CITY UNIVERSITY OF NEW YORK MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ESTROGEN RECEPTOR; IBUPROFEN; PARACETAMOL; PROGESTERONE RECEPTOR;

ADULT; AGE; ANTICOAGULANT THERAPY; ARTICLE; BREAST CANCER; CANCER MORTALITY; CANCER PATIENT; CANCER SURVIVAL; CARDIOVASCULAR DISEASE; CAUSE OF DEATH; DISEASE SEVERITY; DRUG UTILIZATION; EDUCATIONAL STATUS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; OVERALL SURVIVAL; PRIMARY TUMOR; PRIORITY JOURNAL; PROTEIN EXPRESSION; RACE DIFFERENCE; SURVIVAL TIME;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BREAST NEOPLASMS; FEMALE; HUMANS; MIDDLE AGED; MORTALITY; NEW YORK; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; SURVIVAL ANALYSIS;

EID: 84862913805     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-11-1012     Document Type: Article

References (8)

1. Howlader NNA, Krapcho M, Neyman N, Aminou R, Waldron W, Altekruse SF, et al. SEER cancer statistics review, 1975-2008. Bethesda, MD: National Cancer Institute; 2011.
2. Takkouche B, Regueira-Mendez C, Etminan M. Breast cancer and use of nonsteroidal anti-inflammatory drugs: a meta-analysis. J Natl Cancer Inst 2008;100:1439-47.
3. Meric JB, Rottey S, Olaussen K, Soria JC, Khayat D, Rixe O, et al. Cyclooxygenase-2 as a target for anticancer drug development. Crit Rev Oncol Hematol 2006;59:51-64. (Pubitemid 43903278)
4. Brasky TM, Bonner MR, Moysich KB, Ambrosone CB, Nie J, Tao MH, et al. Non-steroidal anti-inflammatory drug (NSAID) use and breast cancer risk in the Western New York Exposures and Breast Cancer (WEB) Study. Cancer Causes Control 2010;21:1503-12.
5. Blair CK, Sweeney C, Anderson KE, Folsom AR. NSAID use and survival after breast cancer diagnosis in post-menopausal women. Breast Cancer Res Treat 2007;101:191-7. (Pubitemid 46115425)
6. Holmes MD, Chen WY, Li L, Hertzmark E, Spiegelman D, Hankinson SE. Aspirin intake and survival after breast cancer. J Clin Oncol 2010;28:1467-72.
7. Wernli KJ, Hampton JM, Trentham-Dietz A, Newcomb PA. Use of antidepressants and NSAIDs in relation to mortality in long-term breast cancer survivors. Pharmacoepidemiol Drug Saf 2011;20:131-7.
8. Coghill AE, Newcomb PA, Chia VM, Zheng Y, Wernli KJ, Passarelli MN, et al. Pre-diagnostic NSAID use but not hormone therapy is associated with improved colorectal cancer survival in women. Br J Cancer 2011;104:763-8.